Paul Edward Kearney

This inventor holds 23 USPTO granted patents and 18 published patent applications and 2 EPO patents, primarily in Cancer Diagnostics. Top assignees: Biodesix, Inc., Integrated Diagnostics, Inc., Indi Molecular, Inc.. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Edward Kearney. Retrieved from https://idiyas.com/inventor/paul-edward-kearney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 18)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 72(Granted Patents)

Location History:

Montreal, CA (2015 - 2017)
Seattle, WA (US) (2014 - 2024)

Company Filing History:

Integrated Diagnostics, Inc.

Sera Prognostics, Inc.

patents

5. 1 out of 1,479

Regeneron Pharmaceuticals, Inc.

patents

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

Lung Cancer

Biomarker Pairs

Preterm Birth

SRM Methods

Clinical Proteomics

Diagnostic Panels

VEGF Capture Agents

AKT Capture Agents

Protein Measurements

Assays

Compositions

Kits

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12480950 - AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING (2025-11-25),

2. 12247980 - Compositions, methods and kits for diagnosis of lung cancer (2025-03-11),

3. 11987846 - Biomarker pairs for predicting preterm birth (2024-05-21),

4. 11913957 - Compositions, methods and kits for diagnosis of lung cancer (2024-02-27),

5. 11662351 - Pregnancy clock proteins for predicting due date and time to birth (2023-05-30),

6. 11467167 - SRM methods in Alzheimer's disease and neurological disease assays (2022-10-11),

7. 11193935 - Compositions, methods and kits for diagnosis of lung cancer (2021-12-07),

8. 10961584 - Biomarker pairs for predicting preterm birth (2021-03-30),

9. 10802027 - Compositions, methods and kits for diagnosis of lung cancer (2020-10-13),

10. 10534002 - Selected reaction monitoring assays (2020-01-14),

11. 10392665 - Biomarker pairs for predicting preterm birth (2019-08-27),

12. 10338074 - Compositions, methods and kits for diagnosis of lung cancer (2019-07-02),

13. 10221214 - Akt-specific capture agents, compositions, and methods of using and making (2019-03-05),

14. 9594085 - Integrated quantification method for protein measurements in clinical proteomics (2017-03-14),

15. 9588127 - Compositions, methods and kits for diagnosis of lung cancer (2017-03-07),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the requested article about inventor Paul Edward Kearney. Here is the structured information based on the data provided:

Title: The Innovative Mind of Paul Edward Kearney: Revolutionizing Healthcare Predictions

Introduction:

Paul Edward Kearney, a renowned inventor based in Seattle, WA (US), is a visionary in the field of healthcare innovations. With an impressive portfolio of 20 patents, Kearney has significantly impacted the medical industry with his groundbreaking inventions.

Latest Patents:

Kearney's latest patents showcase his expertise in transforming healthcare diagnostics and predictions. One of his notable inventions includes "Compositions, methods, and kits for the diagnosis of lung cancer," which revolutionizes the identification of biomarker proteins to diagnose and monitor various lung conditions, including lung cancer subtypes.

Another groundbreaking patent by Kearney is the development of "Pregnancy clock proteins for predicting due date and time to birth." This invention offers a more accurate method of predicting due dates and birth times for pregnancies, surpassing current clinical techniques and enabling early identification of pregnancies likely to deliver ahead of schedule.

Career Highlights:

During his illustrious career, Kearney has made significant contributions to companies such as Integrated Diagnostics, Inc. and Biodesix, Inc. His innovative solutions have not only enhanced healthcare practices but have also paved the way for advancements in diagnostics and predictive medicine.

Collaborations:

Kearney has collaborated with esteemed professionals in the industry, including Xiao-Jun Li and Clive Hayward. Together, they have worked towards pushing the boundaries of healthcare innovation and improving patient outcomes.

Conclusion:

In conclusion, Paul Edward Kearney's relentless pursuit of excellence and dedication to advancing healthcare technologies have positioned him as a trailblazer in the field of medical inventions. His groundbreaking patents continue to shape the future of healthcare diagnostics and predictions, inspiring further innovation in the industry.

If you require any further information or details, feel free to ask.

Profile summary based on public USPTO records.